Keyphrases
Ovarian Cancer
100%
Pregnancy-associated Plasma protein-A (PAPP-A)
100%
Growth Factors
100%
Insulin-like
100%
Ascites
100%
Stanniocalcin-1
100%
Hazard Ratio
45%
PAPP-A2
36%
Mortality Hazard
18%
Malignant Disease
9%
Mortality Risk
9%
Prospective Longitudinal Study
9%
Poor Prognosis
9%
Serum Levels
9%
Overall Survival
9%
4-fold
9%
Protein Concentration
9%
Patient Prognosis
9%
Ovarian Carcinoma
9%
Two-level
9%
Factor System
9%
Peritoneal Dissemination
9%
Tumor Ecosystem
9%
Medicine and Dentistry
Ovarian Cancer
100%
Pregnancy-Associated Plasma Protein A
100%
Somatomedin
100%
Ascites
100%
Hypocalcin
100%
Hazard Ratio
62%
Somatomedin C
50%
Somatomedin B
37%
Disease
12%
Krukenberg Tumor
12%
Neoplasm
12%
Overall Survival
12%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Cancer
100%
Pregnancy Associated Plasma Protein A
100%
Ascites
100%
Somatomedin
100%
Hypocalcin
100%
Somatomedin C
50%
Somatomedin B
37%
Disease
12%
Ovary Carcinoma
12%
Neoplasm
12%
Overall Survival
12%
Biochemistry, Genetics and Molecular Biology
Pregnancy-Associated Plasma Protein A
100%
Insulin-Like Growth Factor
100%
Insulin-Like Growth Factor 1
80%
Insulin-Like Growth Factor 2
60%
STC1
60%
Blood Level
20%
Insulin Blood Level
20%
Overall Survival
20%
Immunology and Microbiology
Blood Plasma
100%
Somatomedin
100%
Somatomedin C
80%
Somatomedin B
60%
Blood Level
20%
Insulin Blood Level
20%
Overall Survival
20%